Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study is a placebo-controlled study in patients with Type 2 Diabetes Mellitus who are
either taking no diabetes medication or who are taking metformin only. This study will
investigate the safety, tolerability, and efficacy of Albiglutide (GSK716155) and will
measure the levels of Albiglutide (GSK716155) in the bloodstream when it is given for 16
weeks. As a comparison, some subjects will receive exenatide instead of Albiglutide
(GSK716155). The study will involve weekly visits for 17 weeks,and less frequent follow-up
visits for an additional 10 weeks. Assessments include repeat blood sampling and monitoring
of any side effects.